Home > Oncology > ASCO 2019 > Gastrointestinal Cancers > Laparascopic surgery; less morbidity, same survival benefits as open surgery in colorectal cancer with liver metastases

Laparascopic surgery; less morbidity, same survival benefits as open surgery in colorectal cancer with liver metastases

Presented By
Dr Ă…smund Avdem Fretland, Oslo University Hospital, Norway
Conference
ASCO 2019
Trial
OSLO-COMET
Medical writer: Dr Rachel H. Giles The randomised OSLO-COMET trial found that laparoscopic surgery did not change chances of survival, when compared to open surgery, to remove metastases that had spread to the liver in patients with colorectal cancer. Overall, patients lived more than 6.5 years after surgery, regardless of whether it was laparoscopic or open [1]. “Laparoscopic liver surgery not only had a lower rate of post-operative complications, an improved quality of life, and was cost-effective, compared to open liver surgery, it also had life expectancies that are similar to open surgery,” explained presenting author Åsmund Avdem Fretland {Oslo University Hospital, Norway). From February 2012 to January 2016 the investigators randomly assigned 280 colorectal cancer patients with liver metastases to either laparoscopic surgery or open surgery. The operations were performed with a liver-sparing technique, which means that the surgeons removed onl...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on